Kiesewetter, B; Willenbacher, E; Willenbacher, W; Egle, A; Neumeister, P; Voskova, D; Mayerhoefer, ME; Simonitsch-Klupp, I; Melchardt, T; Greil, R; Raderer, M; AGMT Investigators.
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Blood. 2017; 129(3): 383-385.
Doi: 10.1182/blood-2016-06-720599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG